Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2006-08-31
2006-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Fasting With Two Meals on Insulin Resistance Indices of Metabolic Syndrome
NCT00429390
Role of Intermittent Islamic Fasting in Management of Metabolic Syndrome
NCT06805526
Does the Energy Restriction Intermittent Fasting Diet Alleviate Metabolic Syndrome Biomarkers?
NCT04502329
Potential Effects of Intermittent Fasting to Metabolic Syndrome
NCT03608800
A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases
NCT03193177
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ramadan Fasting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Type 2 diabetes mellitus,
* Infections,
* Stresses,
* Uremia,
* Acromegaly,
* Glucocorticoid excess,
* Hypertension ,
* Cirrhosis and
* Any addiction or drug therapy and conditions witch cause changes in hs-CRP and fibrinogen levels including infection, trauma, infarction, inflammatory arthritis, various neoplasm and liver diseases.
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Free Islamic University of Medical Sciences
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zahra Vahdat Shariatpanahi, MD
Role: PRINCIPAL_INVESTIGATOR
Islamic Free University of Medical Science
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1345104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.